FNY Investment Advisers LLC Has $6.92 Million Position in Humana Inc. (NYSE:HUM)

FNY Investment Advisers LLC lifted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 6,647.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,260 shares of the insurance provider's stock after purchasing an additional 26,856 shares during the period. Humana comprises 3.6% of FNY Investment Advisers LLC's investment portfolio, making the stock its 2nd largest holding. FNY Investment Advisers LLC's holdings in Humana were worth $6,916,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Marshall Wace LLP grew its position in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock valued at $532,564,000 after buying an additional 774,085 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock valued at $2,340,660,000 after acquiring an additional 738,701 shares during the last quarter. FMR LLC increased its position in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Baupost Group LLC MA acquired a new position in shares of Humana in the 2nd quarter worth approximately $156,933,000. Finally, Thrivent Financial for Lutherans boosted its stake in shares of Humana by 639.8% in the 2nd quarter. Thrivent Financial for Lutherans now owns 385,782 shares of the insurance provider's stock valued at $144,147,000 after purchasing an additional 333,636 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.32% of the company's stock.

Humana Stock Down 1.7 %

Shares of NYSE HUM traded down $4.79 during trading on Tuesday, hitting $282.57. The stock had a trading volume of 1,092,740 shares, compared to its average volume of 1,313,292. The firm has a fifty day moving average of $274.33 and a two-hundred day moving average of $309.10. The company has a market capitalization of $34.02 billion, a PE ratio of 25.03, a PEG ratio of 2.12 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $455.53.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. As a group, equities research analysts forecast that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.25%. Humana's dividend payout ratio is currently 31.36%.

Wall Street Analyst Weigh In

A number of brokerages have commented on HUM. Wells Fargo & Company cut their price target on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a research report on Monday, November 4th. Cantor Fitzgerald reissued a "neutral" rating and issued a $395.00 price target on shares of Humana in a research note on Tuesday, October 1st. Oppenheimer reduced their price objective on shares of Humana from $400.00 to $280.00 and set an "outperform" rating for the company in a research report on Thursday, October 3rd. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Finally, Stephens restated an "equal weight" rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $302.00.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.